KATIE STONICHER: Open Payments
NPI 1598232860 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,076 in 60 payments from 16 companies in 2025. Trend: 2023 $103 · 2024 $680 · 2025 $1,076
Food & beverage: $1,076
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $211 |
| Novo Nordisk Inc | 11 | $206 |
| PFIZER INC. | 8 | $166 |
| AstraZeneca Pharmaceuticals LP | 10 | $164 |
| Lilly USA, LLC | 3 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
| Otsuka America Pharmaceutical, Inc. | 1 | $32 |
| Amgen Inc. | 2 | $30 |
| Corcept Therapeutics | 1 | $26 |
| Kowa Pharmaceuticals America, Inc. | 1 | $25 |
Products named: Ozempic, UBRELVY, PREVNAR 20, AIRSUPRA, NURTEC ODT, FARXIGA, QULIPTA, TRINTELLIX.
Industry payments across LA — which companies pay providers there.
